Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W M Girard

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
Chest|July 1, 1983
Should the FVC be considered in evaluating response to bronchodilator?W M Girard, R W Light
The American Review of Respiratory Disease|May 1, 1993
Clinical features of pulmonary disease caused by rapidly growing mycobacteria. An analysis of 154 patientsD E Griffith, W M Girard, R J Wallace
JAMA|June 29, 1979
Cefazolin vs penicillin. Treatment of uncomplicated pneumococcal pneumoniaS G Jenkinson, R B George, R W Light, et al.
The American Journal of Medicine|October 1, 1980
Parapneumonic effusionsR W Light, W M Girard, S G Jenkinson, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 1, 1995
Adverse events associated with high-dose rifabutin in macrolide-containing regimens for the treatment of Mycobacterium avium complex lung diseaseD E Griffith, B A Brown, W M Girard, et al.
Bulletin of the International Union Against Tuberculosis|January 1, 1976
Epidemiology of atypical mycobacterial disease in Texas and LouisianaW M Girard, C H Ahn, R W Light, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 1, 1996
Azithromycin activity against Mycobacterium avium complex lung disease in patients who were not infected with human immunodeficiency virusD E Griffith, B A Brown, W M Girard, et al.
The Journal of Infectious Diseases|July 7, 2000
Production of interleukin-18 in human tuberculosisR Vankayalapati, B Wizel, S E Weis, et al.
American Journal of Respiratory and Critical Care Medicine|June 1, 1996
Clarithromycin regimens for pulmonary Mycobacterium avium complex. The first 50 patientsR J Wallace, B A Brown, D E Griffith, et al.
The Journal of Infectious Diseases|July 4, 1998
Initial (6-month) results of three-times-weekly azithromycin in treatment regimens for Mycobacterium avium complex lung disease in human immunodeficiency virus-negative patientsD E Griffith, B A Brown, D T Murphy, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Chest|July 1, 1983
Should the FVC be considered in evaluating response to bronchodilator?W M Girard, R W Light
The American Review of Respiratory Disease|May 1, 1993
Clinical features of pulmonary disease caused by rapidly growing mycobacteria. An analysis of 154 patientsD E Griffith, W M Girard, R J Wallace
JAMA|June 29, 1979
Cefazolin vs penicillin. Treatment of uncomplicated pneumococcal pneumoniaS G Jenkinson, R B George, R W Light, et al.
The American Journal of Medicine|October 1, 1980
Parapneumonic effusionsR W Light, W M Girard, S G Jenkinson, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 1, 1995
Adverse events associated with high-dose rifabutin in macrolide-containing regimens for the treatment of Mycobacterium avium complex lung diseaseD E Griffith, B A Brown, W M Girard, et al.
Bulletin of the International Union Against Tuberculosis|January 1, 1976
Epidemiology of atypical mycobacterial disease in Texas and LouisianaW M Girard, C H Ahn, R W Light, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 1, 1996
Azithromycin activity against Mycobacterium avium complex lung disease in patients who were not infected with human immunodeficiency virusD E Griffith, B A Brown, W M Girard, et al.
The Journal of Infectious Diseases|July 7, 2000
Production of interleukin-18 in human tuberculosisR Vankayalapati, B Wizel, S E Weis, et al.
American Journal of Respiratory and Critical Care Medicine|June 1, 1996
Clarithromycin regimens for pulmonary Mycobacterium avium complex. The first 50 patientsR J Wallace, B A Brown, D E Griffith, et al.
The Journal of Infectious Diseases|July 4, 1998
Initial (6-month) results of three-times-weekly azithromycin in treatment regimens for Mycobacterium avium complex lung disease in human immunodeficiency virus-negative patientsD E Griffith, B A Brown, D T Murphy, et al.
Pageof 2